Picture of Chimerix logo

CMRX Chimerix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual cashflow statement for Chimerix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-43.5-173172-82.1-88.4
Depreciation
Non-Cash Items5.3556.9-21610.55.88
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.7316.3-3.422.427.44
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Cash from Operating Activities-36-99.9-46.9-69.1-75
Capital Expenditures-0.058-0.207-0.071-0.089-0.287
Purchase of Fixed Assets
Other Investing Cash Flow Items64.8-43.970.170.771.6
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities64.7-44.17070.671.3
Financing Cash Flow Items0.4261090.6670.3080.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.41112-12.70.3087.05
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash30.1-31.610.41.823.39